It has been almost one year since we passed the Inflation Reduction Act, a bill that caps the cost of insulin for seniors, empowers Medicare to negotiate prescription drug prices and more. And now we're seeing these wins begin to go into effect. As of July 1, 2023, insulin costs are capped at $35 per month for Americans on Medicare. $35 per month as of this past July 1. This is a huge victory worth celebrating. But the work will not and does not stop there. (00:00–01:37)
CLAIM
Asserts that as of July 1, 2023, insulin costs are capped at $35 per month for Medicare beneficiaries.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
